Prognostic factors for male breast cancer: Similarity to female counterparts

Anticancer Research

Volumn 33, Issue 5, 2013, Pages 2227-2232

  Yu, Edward ^a   Stitt, Larry ^a   Vujovic, Olga ^a   Joseph, Kurian ^b   Assouline, Avi ^c   Au, Joseph ^d   Younus, Jawaid ^a   Perera, Francisco ^a   Tai, Patricia ^e  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Department of Radiation Oncology   (France)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Breast cancer; Female; Male; Prognostic factors; Survival

Indexed keywords

COBALT 60; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FEMALE BREAST CANCER; FOLLOW UP; GENDER; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MALE BREAST CANCER; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TUMOR VOLUME;

BREAST CANCER; FEMALE; MALE; PROGNOSTIC FACTORS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84878184747     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jernal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun M: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008. (Pubitemid 351521864)
2. American Cancer Society Cancer Facts & Figures 2012. Atlanta, GA: American Cancer Society.;www.cancer gov/cancer topics/types/breast, last accessed 2012.
3. Joshi MG, Lee AKC, Loda M, Campus MG,Pedersen C, Heatley G and Hughes K: Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 77(3): 490-498, 1996. (Pubitemid 26047570)
4. Crichlow RW: Carcinoma of the male breast. Surg Gynecol Obstet 124: 1011-1019, 1972.
5. Ramantanis G, Besbeas S and Garas JG: Breast cancer in the male: A report of 138 cases. World J Surg 4: 621-624, 1980. (Pubitemid 11141106)
6. Ajaxi DVS, Osegbe DN and Ademiluvi SA: Carcinoma of the male breast in western Africans and the review of the world literature. Cancer 50: 1664-1667, 1982. (Pubitemid 12034568)
7. Erlichman C, Murphy KC and Elhakim T: Male breast cancer: A 13 year review of 89 patients. J Clin Oncol 2: 903-909, 1984. (Pubitemid 14037768)
8. Carlson G, Hafstrom L, Jonsson P: Male breast cancer. Clin Oncol 7: 149-155, 1981. (Pubitemid 11094329)
9. Ouriel K, Lotze MT and Hinshaw JR: Prognostic factors of carcinoma of the male breast. Surg Gynecol Obstet 159: 373-376, 1984. (Pubitemid 14018314)
10. Adami H-O, Holmberg L, Malker B and Ries L: Long term survival in 406 males with breast cancer. Br J Cancer 52: 99-103, 1985. (Pubitemid 15061106)
11. Edge SB, Byrd DR and Compton CC: American Joint Committee on Cancer (AJCC) Manual for Staging of Cancer. 7th ed. New York: Springer-Verlag; Fritz AG, Greene FL, TRotti A editors, pp. 419-460, 2010.
12. Yu E, Suzuki H, Younus J, Elfiki T, Stitt L, Yau G, Vujovic O, Perera F, Lock M and Tai P: The impact of post mastectomy radiation therapy on MBC- a case series. Int J Radiat Oncol Bio Phys 82(2): 696-700, 2012.
13. Cutuli B, Lacroze M, Dilhuydy J M, Veiten M, Lafontan B, Marchal C, Resbent M, Graic Y, Compana F, Moncho-Bernier V, DeGislain C, Tortochaux J, Cuillere FC, Reme-Samon M, Nguyen TD, Lesannier F, LeSimple T, Gamelin E, Hery M and Berlie J: Male breast cancer: Results of the treatments and prognostic factors in 397 cases. Eur J Cancer 31 (12): 1960-1964, 1995. (Pubitemid 26023085)
14. Talluri S, Kakarala R, Karedan T and Kakarala M: Male breast carcinoma in United States: survival rate and determinants of prognosis. J Clin Oncol 29;(Suppl27, abstr 32), 2011.
15. Carter C, Allen C and Henson DE: Relation of tumor size, lymph node status, and survival in 24740 breast cancer cases. Cancer 63: 181-187, 1989. (Pubitemid 19032001)
16. Bonadonna G, Valagussa P, Moliterni A, Zambetti M and Brambilla C: Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node positive breast cancer, the result of 20 years of follow up. N Engl J Med 332 (14): 901-906, 1995.
17. Tai, P, Yu E and Joseph K: Prognostic significance of number of positive nodes: A long-term study of 1-2 nodes versus 3 nodes in breast cancer patients. Int J Radiat Oncol Biol Phys 77: 180-187, 2010.
18. Fox MS: On the diagnosis and treatment of breast cancer. JAMA 241: 489-494, 1979.
19. Anderson WF, Jatoi I, Tse J and Rosenberg PS: Male breast cancer: A population-based comparison with female breast cancer. J Clin Oncol 28(2): 232-239, 2010.
20. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JDF and Feuer EJ: Effect of screening and adjuvant therapy on mortality from breast cancer N Engl J Med 353: 1784-1792, 2005. (Pubitemid 41549890)
21. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK and Berry DD: The decrease in breast cancer incidence in 2003 in United States. N Engl J Med 356:1670-1674, 2007. (Pubitemid 46631679)
22. Mariotto A, Feuer EJ, Harian LC, Wun LM, Johnson KA, Abrams J: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in United States,1975-1999. J Natl Cancer Inst 94: 1626-1634, 2002. (Pubitemid 35378728)
23. Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schafer P, Kurtz J, Sappino AP and Vlastos G: Undertreatment strongly decreases prognosis of breast cancer in elderly women.J Clin Oncol 21(19): 3580-3587, 2003. (Pubitemid 46594049)
24. Naito Y, Mukai H and Nagai S: Elderly breast cancer therapy: A Japanese experience. Jpn J Clin Oncol 40(8): 717-721, 2010.
25. Anelli TF, Anelli A, Tran KN, Lebowohl DE and Borgen PI: Tamoxifen administration is associated with a high rate of treatment-limited symptoms in male breast cancer patients. Cancer 74: 74-77, 1994. (Pubitemid 24187612)
26. Bastiaannet E, Liefers JG, de Craen AJM, Kuppen PJK, van der Water, Portielie JEA, van der Geest LGM, Janssen-Heijnen MLG, Dekker OM, Van de Velde CJH and Westendrop RGJ: Breast cancer in elderly compared to younger patients in the Netherlands:Stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat 124: 801-807, 2010.
27. Kimmick G: Adjuvant chemotherapy for breast cancer in older women: Emerging evidence to aid in decision making. Curr Treat Options Oncol 12(3): 286-301, 2011.